Itraconazole
Tocris Bioscience, part of Bio-Techne | Catalog # 5981
SMO antagonist; acts at different binding site to cyclopamine (Cat No. 1623)
Key Product Details
Description
SMO antagonist; acts at different binding site to cyclopamine (Cat No. 1623)
Product Description
Itraconazole is a SMO antagonist (IC50 = 690 nM); acts at different binding site to cyclopamine (Cat. No. 1623). Also cytochrome p450 inhibitor (IC50 = 16-26 nM). Inhibits cell cycle at G1 phase in vitro and blocks angiogenesis in vivo (IC50 = 160 nM). Antifungal.Product Specifications
Molecular Weight
705.63
Formula
C35H38Cl2N8O4
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
CAS Number
84625-61-6
PubChem ID
3793
InChI Key
OPJPKRNKYPEBBY-YFWMVZQVSA-N
SMILES
CCC(N1N=CN(C2=CC=C(N3CCN(C4=CC=C(C=C4)OC[C@H]5CO[C@@](O5)(C6=C(C=C(C=C6)Cl)Cl)CN7C=NC=N7)CC3)C=C2)C1=O)C.CCC(N8N=CN(C9=CC=C(N%10CCN(C%11=CC=C(C=C%11)OC[C@@H]%12CO[C@](O%12)(C%13=C(C=C(C=C%13)Cl)Cl)CN%14C=NC=N%14)CC%10)C=C9)C8=O)C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 14.11 | 20 with gentle warming |
Preparing Stock Solutions
for Itraconazole
The following data is based on the product molecular weight 705.63
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 7.09 mL | 35.43 mL | 70.86 mL |
| 1 mM | 1.42 mL | 7.09 mL | 14.17 mL |
| 2 mM | 0.71 mL | 3.54 mL | 7.09 mL |
| 10 mM | 0.14 mL | 0.71 mL | 1.42 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Pace Repurposing the clinically efficacious antifungal agent itracon. as an anticancer chemotherapeutic. J.Med.Chem. 2016 PMID: 27014922
- Kim Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell 2013 PMID: 23291299
- Kim Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 2010 PMID: 20385363
- Chong Inhibition of angiogenesis by the antifungal drug itracon. ACS Chem.Biol. 2007 PMID: 17432820
Product Specific Notices for Itraconazole
For research use only
Loading...
Loading...